Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia

Stroke

Volumn 37, Issue 2, 2006, Pages 501-506

  Dingley, John ^a   Tooley, James ^b   Porter, Helen ^c   Thoresen, Marianne ^b  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anesthesia; Asphyxia; Hypoxia; Ischemia; N methyl D aspartate; Neuroprotection; Newborn; Rats; Xenon

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROGEN; OXYGEN; XENON; INHALATION ANESTHETIC AGENT; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CONTROLLED STUDY; DRUG MECHANISM; EXCITOTOXICITY; GAS MIXING; HIPPOCAMPUS; INHALATION ANESTHESIA; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PERINATAL ASPHYXIA; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; THALAMUS; ANIMAL; ASPHYXIA; BRAIN; DRUG EFFECT; FEMALE; MALE; METABOLISM; PATHOLOGY; PILOT STUDY; RANDOMIZATION; TEMPERATURE; TIME;

ANESTHETICS, INHALATION; ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; BRAIN; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PILOT PROJECTS; RANDOM ALLOCATION; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TEMPERATURE; TIME FACTORS; XENON;

EID: 33644848728     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000198867.31134.ac     Document Type: Article

References (42)

1. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696-705.
2. Towfighi J, Zec N, Yager J, Housman C, Vannucci RC. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathol (Berl). 1995;90:375-386.
3. Yue X, Mehmet H, Penrice J, Cooper C, Cady E, Wyatt JS, Reynolds EO, Edwards AD, Squier MV. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischemia. Neuropathol Appl Neurobiol. 1997;23:16-25.
4. Scott RJ, Hegyi L. Cell death in perinatal hypoxic-ischemic brain injury. Neuropathol Appl Neurobiol. 1997;23:307-314.
5. Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, Kirkbride V, Cooper CE, Brown GC, Edwards AD, Wyatt JS, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res. 1995;37:667-670.
6. Thoresen M, Baagenholm R, Loeberg EM, Apricena F, Kjellmer I. Posthypoxic cooling of neonatal rats provides protection against brain injury. Arch Dis Child Fetal Neonatal Ed. 1996;74:F3-F9.
7. Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 1997;99:248-256.
8. Tooley JR, Satas S, Porter H, Silver IA, Thoresen M. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol. 2003;53:65-72.
9. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards DA, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663-670.
10. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol. 2005;32:11-17.
11. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neural. 2005;32:18-24.
12. Rietbrock I. [the biotransformation of inhalation anaesthetics and its relevance to clinical side effects (author's transl)]. Anaesthesist. 1975;24:381-391.
13. Dingley J, Ivanova-Stoilova TM, Grundler S, Wall T. Xenon: recent developments. Anaesthesia. 1999;54:335-346.
14. Dingley J, King R, Hughes L, Terblanche C, Mahon S, Hepp M, Youhana A, Watkins A. Exploration of xenon as a potential cardiostable sedative: a comparison with propofol after cardiac surgery. Anaesthesia. 2001;56:829-835.
15. Preckel B, Schlack W, Heibel T, Rutten H. Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br J Anaesth. 2002;88:264-269.
16. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. Life Sci. 2003;72:1909-1918.
17. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M, Grocott HP. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology. 2003;99:876-881.
18. Rice JE III, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9:131-141.
19. Jaffrin MY, Kesic P. Airway resistance: a fluid mechanical approach. J Appl Physiol. 1974;36:354-361.
20. Trescher WH, Ishiwa S, Johnston MV. Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev. 1997;19:326-338.
21. Romijn HJ, Hofman MA, Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby? Early Hum Dev. 1991;26:61-67.
22. Hagberg H, Bona E, Gilland E, Puka-Sundvall M. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Acta Paediatr Suppl. 1997;422:85-88.
23. Yager J, Towfighi J, Vannucci RC. Influence of mild hypothermia on hypoxic-ischemic brain damage in the immature rat. Pediatr Res. 1993;34:525-529.
24. Yager JY, Asselin J. Effect of mild hypothermia on cerebral energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. Stroke. 1996;27:919-925.
25. Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short-and long-term outcome. Pediatr Res. 1998;43:738-745.
26. Pu Y, Li QF, Zeng CM, Gao J, Qi J, Luo DX, Mahankali S, Fox PT, Gao JH. Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy. AJNR Am J Neuroradiol. 2000;21:203-212.
27. Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J. Cytokines and perinatal brain injury. Neurochem Int. 1997;30:375-383.
28. Hagberg H, Gilland E, Diemer NH, Andine P. Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with nmda and non-nmda receptor antagonists. Biol Neonate. 1994;66:205-213.
29. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth. 2002;89:739-746.
30. Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology. 2003;98:690-698.
31. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, Mehmet H, Edwards AD, Franks NP, Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol. 2005;58:182-193.
32. Ma D, Hossain M, Pettet GK, Luo Y, Lim T, Akimov S, Sanders RD, Franks NP, Maze M. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab. 2005. [Epub ahead of print]
33. Barros RC, Branco LG, Carnio EC. Evidence for thermoregulation by dopamine d1 and d2 receptors in the anteroventral preoptic region during normoxia and hypoxia. Brain Res. 2004;1030:165-171.
34. Yager JY, Armstrong EA, Jaharus C, Saucier DM, Wirrell EC. Preventing hyperthermia decreases brain damage following neonatal hypoxic-ischemic seizures. Brain Res. 2004;1011:48-57.
35. Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci. 1989;9:2809-2818.
36. Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, Olney JW. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol. 1999;408:461-476.
37. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anesthesia. Nature. 1994;367:607-614.
38. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000;287:1056-1060.
39. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature. 1998;396:324.
40. Petzelt C, Taschenberger G, Schmehl W, Kox WJ. Xenon-induced inhibition of ca2+-regulated transitions in the cell cycle of human endothelial cells. Pflugers Arch. 1999;437:737-744.
41. Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology. 2002;96:1485-1491.
42. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J. Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist. Stroke. 2000;31:347-354.